|Day Low/High||53.46 / 54.39|
|52 Wk Low/High||49.03 / 74.94|
Analysts say Tuesday's earnings beat could spell trouble in terms of coping with its $31 billion worth of debt.
All eyes will be on whether the drug company cuts its earnings guidance in tomorrow's earnings release.
It has had a long correction, but a resolution up or down is coming
The Canadian drugmaker could again be hit by its unprofitable Walgreens deal as earnings loom.
U.S. stocks struggle to hold onto slight gains after a terrorist attack overnight casts a shadow over global markets.
Herbalife stock lifted on FTC investigation results while Xerox reportedly rejects R.R. Donnelley's merger proposal.
Costco and Zumiez were able to benefit from their strong June comps, while Walgreens Buckle and L Brands went the other way.
U.S. stocks shook off earlier weakness to close higher after the Fed's June meeting minutes stressed a prudent approach to monetary policy.
U.S. stocks moved lower on Wednesday, as Brexit fears pushed investors into safe-haven assets.
Walgreens reports mixed quarterly results, Nortek bought for $2.8 billion as stocks point lower.
On Wednesday, July 6, investors will get the minutes of the Federal Reserve's June meeting and earnings from Walgreens.
For the week of July 4, investors await earnings from Walgreens Boots Alliance, the FOMC minutes and the June jobs report.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on earnings from Walgreens Boots Alliance and PepsiCo, released next week.
The federal government has turned violently against these deals.
There are some good plays out there, but no one seems to want the ball in this gameless market.
Without it, any rally would just be a short-covering bump.
When a stock like WBA isn't trading at a discount, try put options.
The troubled Canadian drugmaker is under increased pressure to sell assets, and quickly.
Sad weekend. Sad day. The big business news item -- Microsoft (MSFT) acquiring LinkedIn (LNKD), but I don't view this as a meaningful positive. I added to my Nasdaq short today at attractive prices. "Trade of the Week" -- long Twitter (TWTR). Odd...
Papa is set to meet with Walgreens management in hopes of ironing out "speed bumps."
Walgreens formally ended its relationship with Theranos.
Walgreens and Theranos split as Apple focuses on Siri and investors wait for the Fed decision.
A Clinton presidency will ensure upending support for ObamaCare, while a Trump presidency won't be able to touch it. Either way, Walgreens Boots Alliance wins.
A close below $74 could result in another leg lower to the mid-$60s.
What should investors make of private equity firms scaling back some of their prized positions?
Investors watching 13F portfolioS for investment clues are reminded to look at a fund's whole portfolio before following too closely in its footsteps
Jim Cramer says Target's first quarter earnings report 'stung' because he was expecting the retailer to do much better.
Jim Cramer says UnitedHealth's stock is going much higher, and it is a 'terrific' name to own.
UnitedHealth Group is a terrific stock to own and the company proved itself with an impressive earnings report this week, says Jim Cramer.